Regulatory Scrutiny Notice: The GLP-1 telehealth industry and compounded GLP-1 medications have been under active regulatory scrutiny
The new figure reflects trends influencing how these drugs are priced, how long patients stay on them, and how patient populations are segmented, says Asad Haider, head of the healthcare business unit within Goldman Sachs Research
Shop with expert advice from Katie & Family in their latest video LEDISA GLP-1 Patches
This perspective synthesizes mechanistic insights into EMFs bioeffects through three interconnected axes: (1) Calcium signaling as a central biosensor, translating EMFs stimuli into oncogenic processes via piezoelectric and ionic mechanisms
In 2024, semaglutide 2.4 mg (Wegovy) received FDA approval for cardiovascular risk reduction in adults with established cardiovascular disease and either overweight or obesity, based on the SELECT trial
The orphan nuclear receptor RORt directs the differentiation program of proinflammatory IL-17 + T helper cells
